SCHEMBL4824

SCHEMBL4824

[CH]1Nc2ccccc2N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083622 0.78 GAA (0.31) —
SCHEMBL29848588 0.77 MAPT (0.38) —
SCHEMBL1996673 0.77 MAPT (0.38) —
SCHEMBL20554671 0.77 MAPT (0.38) —
SCHEMBL11699088 0.72 GRK6 (0.50) —
SCHEMBL29369547 0.67 GAA (0.59) —
SCHEMBL76607 0.67 — —
SCHEMBL2676730 0.67 GAA (0.59) —
SCHEMBL624418 0.67 GAA (0.59) —
Fluoride SCHEMBL6264312 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11177 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024140595-A1 TRICYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF 珂阑(上海)医药科技有限公司 2024-07-04 — — WO claimed
CN-118255685-A Tricyclic compound, pharmaceutical composition and application thereof 珂阑(上海)医药科技有限公司 2024-06-28 — — CN claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 — — US claimed
CN-117794343-A Composite material, preparation method thereof, photoelectric device and display device TCL科技集团股份有限公司 2024-03-29 — — CN claimed
EP-4337220-A1 SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS Saint Joseph's University (US) 2024-03-20 — — EP claimed
US-20240076291-A1 MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-03-07 — — US claimed
CN-117529202-A Organometallic compound, light-emitting device, electronic apparatus, and electronic device 三星显示有限公司 2024-02-06 — — CN claimed
CN-117135987-A Organometallic compound, light-emitting device including the same, electronic device, and electronic device 三星显示有限公司 2023-11-28 — — CN claimed
CN-114341103-B Aminoguanhydrazones as retrograde transport stabilizers useful in the treatment of neurological diseases 圣拉斐尔医院有限公司 2023-11-10 — — CN claimed
EP-4251149-A1 MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS Merck Sharp & Dohme LLC (US) 2023-10-04 — — EP claimed
EP-0166696-B1 LUBRICANT ADDITIVES CIBA-GEIGY AG (CH) 1989-07-19 — — EP claimed
EP-0120589-B1 IMIDAZO-HETEROCYCLIC COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-08 — — EP claimed
EP-0233140-A1 Lubricant additives containing sulphur and nitrogen CIBA-GEIGY AG (CH) 1987-08-19 — — EP claimed
US-4621084-A CARDIOTONIC, ANTIULCER FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-11-04 — — US claimed
EP-0166696-A2 Lubricant additives CIBA-GEIGY AG (CH) 1986-01-02 — — EP claimed
EP-0120589-A1 Imidazo-heterocyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-03 — — EP claimed
EP-0014928-B1 PIPERIDINOPROPYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS Roche Diagnostics GmbH (DE) 1982-05-05 — — EP claimed
US-4288442-A Inhibiting adrenergic β-receptors with piperidinopropyl derivatives BOEHRINGER MANNHEIM GMBH (DE) 1981-09-08 — — US claimed
US-4267340-A BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-12 — — US claimed
EP-0018417-A1 Novel piperidine derivatives and pharmaceutical compositions containing them KYOWA HAKKO KOGYO CO., LTD (JP) 1980-11-12 — — EP claimed
Send feedback